This week in Washington IP news, the Senate Judiciary Committee will consider a series of bills that could limit pharmaceutical patent owners’ ability to enforce their patents against generic drug makers. Over in the House of Representatives, the House Science Committee will mark up a series of bills to support research and development as well as technology transfer and commercialization, while the House Europe Subcommittee will explore international case studies in offshore wind renewable energy innovation. Elsewhere, the American Enterprise Institute focuses on developments in the private commercial space sector, while the USPTO celebrates 75 years of the Lanham Act’s codification of U.S. trademark law this Tuesday.
Recent Posts
- Coke Stewart’s Recent Show Cause Order Offers Hope for Addressing Serial Patent Challenges
- The USPTO Should Reintroduce the AFCP Program—Now
- What Fintiv v. PayPal Means for Software and AI Patent Practice
- Despite Tweaks, PREVAIL 2025 Would Still Transform the PTAB
- Patent Eligibility Reform Returns to the Hill: PERA 2025 Explained